[Federal Register Volume 73, Number 155 (Monday, August 11, 2008)]
[Notices]
[Pages 46626-46627]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-18426]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health Advisory
Board on Radiation and Worker Health
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Meeting Times and Dates:
(All times are Pacific Daylight Time)
1 p.m.-5 p.m., September 2, 2008.
9 a.m.-5 p.m., September 3, 2008.
9 a.m.-2 p.m., September 4, 2008.
Public Comment Times and Dates:
(All times are Pacific Daylight Time)
5 p.m.-6 p.m., September 2, 2008.
7:30 p.m.-8:30 p.m., September 3, 2008.
Place: Crowne Plaza Redondo Beach, 300 N. Harbor Drive, Redondo
Beach, California 90277, Telephone: (310) 318-7705, Fax: (310) 376-
61930.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 75 to 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act (EEOICPA) of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. The key functions of the Advisory Board include
providing advice on the development of probability of causation
[[Page 46627]]
guidelines which have been promulgated by the Department of Health and
Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort.
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2009.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose (c) upon request by the
Secretary, HHS, advising the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their radiation
dose, and on whether there is reasonable likelihood that such radiation
doses may have endangered the health of members of this class.
Matters To Be Discussed: The agenda for the Advisory Board meeting
includes: NIOSH Program Status Update; Special Exposure Cohort (SEC)
Petitions for: Pantex; Connecticut Aircraft Nuclear Engine Laboratory
(CANEL); SEC Petition Updates: Chapman Valve; Special Exposure Cohort
(SEC) Petition Status Update(s); Department of Labor (DOL) Update;
Department of Energy (DOE) Update; Work Group reports; Subcommittee on
Dose Reconstruction Reviews Report; and Board Future Plans and
Schedules.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted according the policy provided below. Any written comments
received will be provided at the meeting and should be submitted to the
contact person below well in advance of the meeting.
Policy on Redaction of Board Meeting Transcripts (Public Comment),
if a person making a comment gives his or her name, no attempt will be
made to redact that name. NIOSH will take reasonable steps to ensure
that individuals making public comment are aware of the fact that their
comments (including their name, if provided) will appear in a
transcript of the meeting posted on a public Web site. Such reasonable
steps include: (a) A statement read at the start of each public comment
period stating that transcripts will be posted and names of speakers
will not be redacted; (b) A printed copy of the statement mentioned in
(a) above will be displayed on the table where individuals sign up to
make public comment; (c) A statement such as outlined in (a) above will
also appear with the agenda for a Board Meeting when it is posted on
the NIOSH Web site; (d) A statement such as in (a) above will appear in
the Federal Register notice that announces Board and Subcommittee
meetings. If an individual in making a statement reveals personal
information (e.g., medical information) about themselves that
information will not usually be redacted. The NIOSH Freedom of
Information Act coordinator will, however, review such revelations in
accordance with the Freedom of Information Act and the Federal Advisory
Committee Act and if deemed appropriate, will redact such information.
All disclosures of information concerning third parties will be
redacted. If it comes to the attention of the Designated Federal
Officer (DFO) that an individual wishes to share information with the
Board but objects to doing so in a public forum, the DFO will work with
that individual, in accordance with the Federal Advisory Committee Act,
to find a way that the Board can hear such comments.
Contact Person for More Information: Zaida Burgos, Committee
Management Specialist, NIOSH, CDC, 1600 Clifton Road, Atlanta, Georgia
30033, Telephone (404) 498-2548 Toll Free: (800) CDC-INFO, E-mail
[email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: August 4, 2008.
Daniel Riedford,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E8-18426 Filed 8-8-08; 8:45 am]
BILLING CODE 4163-18-P